Skip to content

A real-world study based on the analysis of the current status, efficacy, and safety of glucose-lowering regimens in outpatients and inpatients with diabetic kidney disease in West China Hospital, Sichuan University

A real-world study based on the analysis of the current status, efficacy, and safety of glucose-lowering regimens in outpatients and inpatients with diabetic kidney disease in West China Hospital, Sichuan University

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300068497
Enrollment
Unknown
Registered
2023-02-21
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic kidney disease

Interventions

Other hypoglycemic drugs group:None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Age = 18 years; (2) Clinical diagnosis of T2DM;

Exclusion criteria

Exclusion criteria: (1) Malignancy,(2) superimposed other glomerular diseases,(3) e-GFR < 15ml / min /1.73m2 or had entered dialysis, (4) follow-up time < 1 year and (5) incomplete data.

Design outcomes

Primary

MeasureTime frame
Glomerular filtration rate;the change of eGFR;eGFR < 15 min / min / 1.73m2) or / and continuous renal replacement therapy (hemophoresis / abdominal permeabilization / renal transplantation);death;Incidence of hospitalization, hospital costs;Incidence of hypoglycemia, ketoacidosis;

Secondary

MeasureTime frame
red blood cells;white blood cells;platelets;hemoglobin;total cholesterol;triglyceride;low density lipoprotein;high density lipoprotein;creatinine;cystatin C;Urine microalbumin/creatinine;Glycated hemoglobin;

Countries

China

Contacts

Public ContactFang Liu

West China Hospital,Sichuan University

liufangfh@163.com18980601214

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026